KORU Medical Systems (KRMD) to Post Earnings on Wednesday

KORU Medical Systems (NASDAQ:KRMD) is expected to be posting its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect KORU Medical Systems to announce earnings of ($0.02) per share and revenue of $11.6180 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

KORU Medical Systems Price Performance

KRMD stock opened at $4.01 on Wednesday. The stock has a market capitalization of $184.18 million, a PE ratio of -80.20 and a beta of 0.41. The company’s 50-day moving average is $4.12 and its 200-day moving average is $4.45. KORU Medical Systems has a 1 year low of $3.20 and a 1 year high of $6.61.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Weiss Ratings lowered KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, July 15th. Wall Street Zen upgraded KORU Medical Systems from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $7.25.

Insider Buying and Selling

In related news, insider Adam R. Kalbermatten acquired 12,500 shares of the stock in a transaction dated Thursday, June 11th. The stock was purchased at an average cost of $3.94 per share, with a total value of $49,250.00. Following the completion of the purchase, the insider directly owned 312,500 shares in the company, valued at $1,231,250. This trade represents a 4.17% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders purchased 28,000 shares of company stock worth $109,430. Insiders own 18.50% of the company’s stock.

Institutional Investors Weigh In On KORU Medical Systems

Institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. boosted its holdings in KORU Medical Systems by 24.8% during the 4th quarter. Invesco Ltd. now owns 27,873 shares of the company’s stock worth $162,000 after acquiring an additional 5,546 shares during the last quarter. Occudo Quantitative Strategies LP bought a new position in shares of KORU Medical Systems during the fourth quarter valued at about $127,000. Price T Rowe Associates Inc. MD lifted its position in shares of KORU Medical Systems by 26.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,036 shares of the company’s stock valued at $158,000 after purchasing an additional 5,649 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in KORU Medical Systems by 28.3% during the fourth quarter. Russell Investments Group Ltd. now owns 195,773 shares of the company’s stock worth $1,137,000 after purchasing an additional 43,215 shares during the last quarter. Finally, Royal Bank of Canada grew its position in KORU Medical Systems by 8,719.9% in the 4th quarter. Royal Bank of Canada now owns 133,004 shares of the company’s stock worth $773,000 after purchasing an additional 131,496 shares in the last quarter. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.